TL43: Are global tests a practical option for regulatory clinical trials?
*Pablo E. Bonangelino, FDA/CDRH/OSB/DBS
Keywords: global test, non-parametric
A global test can be an attractive alternative to multiple hypothesis tests in a trial with more than one important measured outcome. Such a test typically uses a non-parametric combination of several outcomes in one combined measure. However, adequately controlling type I error could involve non-trivial additional computations in the presence of the non-parametric Behrens-Fisher problem. In addition, determining the sample size for a trial using a global test may also present challenges. Thus, it is a question whether the advantages of such a test outweigh the difficulties in its implementation.
Q1: Have you ever used or recommended a global test in a regulatory trial? Q2: Can you describe any situations where a global test might have been useful, but was not used? Q3: Are you aware of any research on the use of global tests with highly correlated component domains?
April 30 - May 22, 2013
Invited Abstract Submission Open
June 4, 2013
Online Registration Opens
August 9 - August 23, 2013
Invited Abstract Editing
August 23, 2013
Short Course materials due from Instructors
August 26, 2013
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC